NCT00440128 2017-08-04The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With CancerGlaxoSmithKlinePhase 1 Completed12 enrolled
NCT00978549 2013-08-07Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach CancerNational Cancer Institute (NCI)Phase 3 Completed320 enrolled